跳至主要内容
临床试验/NCT05432817
NCT05432817已完成不适用

PTSD Treatment for Incarcerated Men and Women: WPP

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2024年1月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
117
试验地点
1
主要终点
Change in PTSD Checklist for DSM-5 (PCL-5) severity score

研究概览

简要总结

Study examining the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of individuals for both CPT and waitlist control in both populations (180 participants total).

详细描述

Overall Study Objectives:

The primary objectives of this project include:

  1. Determine the effectiveness of CPT in reducing PTSD symptom severity;
  2. Identify putative psychological mechanisms of response to CPT through pre-, mid-, and post-intervention measures of PTSD symptom severity as well as measures of hopelessness, self-blame, and negative self-related thoughts.

Prior to beginning any study procedures, informed consent will be obtained orally and in writing. During the informed consent process, eligible participants will be provided with detailed information about the study, including their right to refuse or discontinue participation at any time and the fact that their decision to participate or decline will have no bearing on their standing within the criminal justice system.

Potential participants will be contacted by calling them over the phone system within the prison. When they arrive to the private testing room, they are asked if they would like to learn about the study and potentially participate. If so, participants undergo consent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years old or older
  • meet PCL-5 criteria for current PTSD diagnosis within 2 months of enrollment
  • no scheduled release date before the end of the treatment group
  • able to understand the consent form as measured by the consent quiz
  • have not participated in the previous CPT groups with UW project
  • No active symptoms of psychosis that would interfere with the individual's ability to participate in the group
  • No active suicidal ideation with intent or plan
  • Able and willing to participate in group therapy

排除标准

  • 未提供

研究组 & 干预措施

Cognitive Processing Therapy (CPT) group

Experimental

Participant groups to receive CPT to treat PTSD

干预措施: Cognitive Processing Therapy (Behavioral)

Waitlist Control

No Intervention

Participant groups will provide data as a control group first, and will then receive CPT to treat PTSD

结局指标

主要结局

Change in PTSD Checklist for DSM-5 (PCL-5) severity score

时间窗: baseline (two weeks prior to intervention), up to 6 weeks (mid-intervention), up to 13 weeks (one week post-intervention), up to 18 weeks (one month post-treatment), and up to 26 weeks (three months post-treatment)

PTSD symptom severity is measured by PCL-5 questionnaire (scores from 0, no symptoms, to 80, high severity); primary measure of intervention efficacy

次要结局

  • Ratings from 0-5 by clinical supervisors on therapist adherence to five session elements(Up to 7 weeks (by the end of the 12th session))
  • Ratings 1-7 by clinical supervisors on quality of session elements delivered by therapist(Up to 7 weeks (by the end of the 12th session))
  • Change in score on the Beck Depression Inventory 2 (BDI-II)(baseline (two weeks prior to intervention), up to 6 weeks (mid-intervention), up to 13 weeks (one week post-intervention), up to 18 weeks (one month post-treatment), and up to 26 weeks (three months post-treatment))
  • Change in score on the Beck Anxiety Inventory (BAI)(baseline (two weeks prior to intervention), up to 6 weeks (mid-intervention), up to 13 weeks (one week post-intervention), up to 18 weeks (one month post-treatment), and up to 26 weeks (three months post-treatment))
  • Percentage of participants endorsing 2 or higher on Q9 of BDI-II(baseline (two weeks prior to intervention), up to 6 weeks (mid-intervention), up to 13 weeks (one week post-intervention), up to 18 weeks (one month post-treatment), and up to 26 weeks (three months post-treatment))
  • Ratings from 0-5 by clinical supervisors on therapist adherence to five session elements(Up to 7 weeks (by the end of the 12th session))
  • Ratings 1-7 by clinical supervisors on quality of session elements delivered by therapist(Up to 7 weeks (by the end of the 12th session))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验